Shiva Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -116.67%
(FY 2023)
- Ebitda -116.67%
(FY 2023)
- Net Worth -28.29%
(FY 2023)
- Total Assets %
(FY 2023)
About Shiva Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kapil Bhardwaj and Kunal Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U51109BR2009PTC014300
- Company No.
014300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shiva Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Bhardwaj  | Managing Director | 04-Mar-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Bhardwaj | Director | 04-Mar-2009 | Current |
Financial Performance of Shiva Lifescience.
Shiva Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 116.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiva Lifescience?
In 2023, Shiva Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shiva Biogenetic Pharmaceuticals Private LimitedActive 19 years 3 monthsKapil Bhardwaj is a mutual person
- Shiva Biogenetic Laboratories Private LimitedActive 8 years 5 months
Kapil Bhardwaj and Kunal Bhardwaj are mutual person
- Industrialent Chemicals Private LimitedActive 3 years 8 months
Kapil Bhardwaj and Kunal Bhardwaj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shiva Lifescience?
Unlock and access historical data on people associated with Shiva Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiva Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiva Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
